Skip to main content

Prion Diseases

  • Chapter
  • First Online:
Book cover Viral Infections of the Human Nervous System

Part of the book series: Birkhäuser Advances in Infectious Diseases ((BAID))

Abstract

Prion diseases are infectious neurodegenerative diseases that have fascinated scientists for decades. They can occur spontaneously, iatrogenically, or be inherited through mutation of the prion protein gene Prnp. Instead of a virus, the infectious agent is a corrupted form of the naturally occurring prion protein. Disease results when this corrupted form (PrPSc) converts the normally expressed prion protein (PrPC) into the abnormal conformation, leading to protein aggregation and ultimately neuronal death. Different structures of PrPSc exist as different strains of prions, some of which can cross species barriers, and each strain can produce a unique phenotype. Clinical signs generally include dementia and ataxia, but because these diseases are relatively rare and can mimic other syndromes, diagnosis is often missed or delayed. While no one diagnostic test is 100 % accurate, new tests are on the horizon which may lead to earlier diagnosis. This, in turn, may facilitate therapy efforts, because as of now, there are no effective treatments for prion disease.

Keywords

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aiguabella M, Falip M, Veciana M, Bruna J, Palasi A, Corral L, Herrero JI, Boluda S, Mora J, Iranzo A, Serrano C (2010) Refractory nonconvulsive status epilepticus in Creutzfeldt-Jakob disease. Epileptic Disord 12:239–242. doi:10.1684/epd.2010.0318

    PubMed  Google Scholar 

  • Alper T, Cramp WA, Haig DA, Clarke MC (1967) Does the agent of scrapie replicate without nucleic acid? Nature 214:764–766

    PubMed  CAS  Google Scholar 

  • Anderson RM, Donnelly CA, Ferguson NM, Woolhouse ME, Watt CJ, Udy HJ, MaWhinney S, Dunstan SP, Southwood TR, Wilesmith JW, Ryan JB, Hoinville LJ, Hillerton JE, Austin AR, Wells GA (1996) Transmission dynamics and epidemiology of BSE in British cattle. Nature 382:779–788. doi:10.1038/382779a0

    PubMed  CAS  Google Scholar 

  • Atarashi R, Sano K, Satoh K, Nishida N (2011a) Real-time quaking-induced conversion: a highly sensitive assay for prion detection. Prion 5:150–153. doi:10.4161/pri.5.3.16893

    PubMed  CAS  Google Scholar 

  • Atarashi R, Moore RA, Sim VL, Hughson AG, Dorward DW, Onwubiko HA, Priola SA, Caughey B (2007) Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat Methods 4:645–650. doi:10.1038/nmeth1066

    PubMed  CAS  Google Scholar 

  • Atarashi R, Wilham JM, Christensen L, Hughson AG, Moore RA, Johnson LM, Onwubiko HA, Priola SA, Caughey B (2008) Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat Methods 5:211–212. doi:10.1038/nmeth0308-211

    PubMed  CAS  Google Scholar 

  • Atarashi R, Satoh K, Sano K, Fuse T, Yamaguchi N, Ishibashi D, Matsubara T, Nakagaki T, Yamanaka H, Shirabe S, Yamada M, Mizusawa H, Kitamoto T, Klug G, McGlade A, Collins SJ, Nishida N (2011b) Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med 17:175–178. doi:10.1038/nm.2294

    PubMed  CAS  Google Scholar 

  • Baron D, Assaraf YG, Cohen N, Aronheim A (2002) Lack of plasma membrane targeting of a G172D mutant thiamine transporter derived from Rogers syndrome family. Mol Med 8:462–474

    PubMed  CAS  Google Scholar 

  • Barret A, Tagliavini F, Forloni G, Bate C, Salmona M, Colombo L, De Luigi A, Limido L, Suardi S, Rossi G, Auvre F, Adjou KT, Sales N, Williams A, Lasmezas C, Deslys JP (2003) Evaluation of quinacrine treatment for prion diseases. J Virol 77:8462–8469

    PubMed  CAS  Google Scholar 

  • Barria MA, Mukherjee A, Gonzalez-Romero D, Morales R, Soto C (2009) De novo generation of infectious prions in vitro produces a new disease phenotype. PLoS Pathog 5:e1000421. doi:10.1371/journal.ppat.1000421

    PubMed  Google Scholar 

  • Barry RA, McKinley MP, Bendheim PE, Lewis GK, DeArmond SJ, Prusiner SB (1985) Antibodies to the scrapie protein decorate prion rods. J Immunol 135:603–613

    PubMed  CAS  Google Scholar 

  • Bartz JC, Dejoia C, Tucker T, Kincaid AE, Bessen RA (2005) Extraneural prion neuroinvasion without lymphoreticular system infection. J Virol 79:11858–11863. doi:10.1128/JVI.79.18.11858-11863.2005

    PubMed  CAS  Google Scholar 

  • Berardi VA, Cardone F, Valanzano A, Lu M, Pocchiari M (2006) Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation. Transfusion 46:652–658. doi:10.1111/j.1537-2995.2006.00763.x

    PubMed  CAS  Google Scholar 

  • Bessen RA, Marsh RF (1992) Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J Virol 66:2096–2101

    PubMed  CAS  Google Scholar 

  • Bessen RA, Martinka S, Kelly J, Gonzalez D (2009) Role of the lymphoreticular system in prion neuroinvasion from the oral and nasal mucosa. J Virol 83:6435–6445. doi:10.1128/JVI.00018-09

    PubMed  CAS  Google Scholar 

  • Bianca M, Bianca S, Vecchio I, Raffaele R, Ingegnosi C, Nicoletti F (2003) Gerstmann-Straussler-Scheinker disease with P102L-V129 mutation: a case with psychiatric manifestations at onset. Ann Genet 46:467–469

    PubMed  Google Scholar 

  • Bishop MT, Will RG, Manson JC (2010) Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. Proc Natl Acad Sci USA 107:12005–12010. doi:10.1073/pnas.1004688107

    PubMed  CAS  Google Scholar 

  • Bolton DC, McKinley MP, Prusiner SB (1982) Identification of a protein that purifies with the scrapie prion. Science 218:1309–1311

    PubMed  CAS  Google Scholar 

  • Bone I, Belton L, Walker AS, Darbyshire J (2008) Intraventricular pentosan polysulphate in human prion diseases: an observational study in the UK. Eur J Neurol 15:458–464. doi:10.1111/j.1468-1331.2008.02108.x

    PubMed  CAS  Google Scholar 

  • Borchelt DR, Taraboulos A, Prusiner SB (1992) Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J Biol Chem 267:16188–16199

    PubMed  CAS  Google Scholar 

  • Brandner S, Isenmann S, Raeber A, Fischer M, Sailer A, Kobayashi Y, Marino S, Weissmann C, Aguzzi A (1996) Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379:339–343. doi:10.1038/379339a0

    PubMed  CAS  Google Scholar 

  • Brandner S, Klein MA, Frigg R, Pekarik V, Parizek P, Raeber A, Glatzel M, Schwarz P, Rulicke T, Weissmann C, Aguzzi A (2000) Neuroinvasion of prions: insights from mouse models. Exp Physiol 85:705–712

    PubMed  CAS  Google Scholar 

  • Brandner S, Whitfield J, Boone K, Puwa A, O’Malley C, Linehan JM, Joiner S, Scaravilli F, Calder I, Alpers MP, Wadsworth JD, Collinge J (2008) Central and peripheral pathology of kuru: pathological analysis of a recent case and comparison with other forms of human prion disease. Philos Trans R Soc Lond B Biol Sci 363:3755–3763. doi:10.1098/rstb.2008.0091

    PubMed  Google Scholar 

  • Brown P, Brandel JP, Preece M, Sato T (2006) Iatrogenic Creutzfeldt-Jakob disease: the waning of an era. Neurology 67:389–393. doi:10.1212/01.wnl.0000231528.65069.3f

    PubMed  Google Scholar 

  • Bruce ME (1993) Scrapie strain variation and mutation. Br Med Bull 49:822–838

    PubMed  CAS  Google Scholar 

  • Bruce ME, Fraser H (1991) Scrapie strain variation and its implications. Curr Top Microbiol Immunol 172:125–138

    PubMed  CAS  Google Scholar 

  • Bruce ME, McConnell I, Will RG, Ironside JW (2001) Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet 358:208–209

    PubMed  CAS  Google Scholar 

  • Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, McCardle L, Chree A, Hope J, Birkett C, Cousens S, Fraser H, Bostock CJ (1997) Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature 389:498–501. doi:10.1038/39057

    PubMed  CAS  Google Scholar 

  • Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C (1993) Mice devoid of PrP are resistant to scrapie. Cell 73:1339–1347

    PubMed  CAS  Google Scholar 

  • Carlson GA, Kingsbury DT, Goodman PA, Coleman S, Marshall ST, DeArmond S, Westaway D, Prusiner SB (1986) Linkage of prion protein and scrapie incubation time genes. Cell 46:503–511

    PubMed  CAS  Google Scholar 

  • Castilla J, Saa P, Hetz C, Soto C (2005) In vitro generation of infectious scrapie prions. Cell 121:195–206. doi:10.1016/j.cell.2005.02.011

    PubMed  CAS  Google Scholar 

  • Caughey B, Raymond GJ (1991) The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J Biol Chem 266:18217–18223

    PubMed  CAS  Google Scholar 

  • Caughey B, Raymond GJ (1993) Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J Virol 67:643–650

    PubMed  CAS  Google Scholar 

  • Caughey B, Raymond GJ, Bessen RA (1998) Strain-dependent differences in beta-sheet conformations of abnormal prion protein. J Biol Chem 273:32230–32235

    PubMed  CAS  Google Scholar 

  • Caughey B, Raymond GJ, Ernst D, Race RE (1991a) N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J Virol 65:6597–6603

    PubMed  CAS  Google Scholar 

  • Caughey B, Brown K, Raymond GJ, Katzenstein GE, Thresher W (1994) Binding of the protease-sensitive form of PrP (prion protein) to sulfated glycosaminoglycan and congo red [corrected]. J Virol 68:2135–2141

    PubMed  CAS  Google Scholar 

  • Caughey BW, Dong A, Bhat KS, Ernst D, Hayes SF, Caughey WS (1991b) Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 30:7672–7680

    PubMed  CAS  Google Scholar 

  • Chang CC, Eggers SD, Johnson JK, Haman A, Miller BL, Geschwind MD (2007) Anti-GAD antibody cerebellar ataxia mimicking Creutzfeldt-Jakob disease. Clin Neurol Neurosurg 109:54–57. doi:10.1016/j.clineuro.2006.01.009

    PubMed  Google Scholar 

  • Chesebro B, Trifilo M, Race R, Meade-White K, Teng C, LaCasse R, Raymond L, Favara C, Baron G, Priola S, Caughey B, Masliah E, Oldstone M (2005) Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308:1435–1439. doi:10.1126/science.1110837

    PubMed  CAS  Google Scholar 

  • Chin RL, Latov N (2005) Central nervous system manifestations of rheumatologic diseases. Curr Opin Rheumatol 17:91–99

    PubMed  Google Scholar 

  • Chohan G, Pennington C, Mackenzie JM, Andrews M, Everington D, Will RG, Knight RS, Green AJ (2010) The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review. J Neurol Neurosurg Psychiatry 81:1243–1248. doi:10.1136/jnnp.2009.197962

    PubMed  CAS  Google Scholar 

  • Cobb NJ, Sonnichsen FD, McHaourab H, Surewicz WK (2007) Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure. Proc Natl Acad Sci USA 104:18946–18951. doi:10.1073/pnas.0706522104

    PubMed  CAS  Google Scholar 

  • Cohen D, Kutluay E, Edwards J, Peltier A, Beydoun A (2004) Sporadic Creutzfeldt-Jakob disease presenting with nonconvulsive status epilepticus. Epilepsy Behav 5:792–796. doi:10.1016/j.yebeh.2004.06.019

    PubMed  Google Scholar 

  • Collinge J, Clarke AR (2007) A general model of prion strains and their pathogenicity. Science 318:930–936. doi:10.1126/science.1138718

    PubMed  CAS  Google Scholar 

  • Collinge J, Palmer MS, Dryden AJ (1991) Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 337:1441–1442

    PubMed  CAS  Google Scholar 

  • Collinge J, Sidle KC, Meads J, Ironside J, Hill AF (1996) Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature 383:685–690. doi:10.1038/383685a0

    PubMed  CAS  Google Scholar 

  • Collinge J, Harding AE, Owen F, Poulter M, Lofthouse R, Boughey AM, Shah T, Crow TJ (1989) Diagnosis of Gerstmann-Straussler syndrome in familial dementia with prion protein gene analysis. Lancet 2:15–17

    PubMed  CAS  Google Scholar 

  • Collinge J, Gorham M, Hudson F, Kennedy A, Keogh G, Pal S, Rossor M, Rudge P, Siddique D, Spyer M, Thomas D, Walker S, Webb T, Wroe S, Darbyshire J (2009) Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial. Lancet Neurol 8:334–344. doi:10.1016/S1474-4422(09)70049-3

    PubMed  CAS  Google Scholar 

  • Collins SJ, Lewis V, Brazier M, Hill AF, Fletcher A, Masters CL (2002) Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model. Ann Neurol 52:503–506. doi:10.1002/ana.10336

    PubMed  CAS  Google Scholar 

  • Collins SJ, Sanchez-Juan P, Masters CL, Klug GM, van Duijn C, Poleggi A, Pocchiari M, Almonti S, Cuadrado-Corrales N, de Pedro-Cuesta J, Budka H, Gelpi E, Glatzel M, Tolnay M, Hewer E, Zerr I, Heinemann U, Kretszchmar HA, Jansen GH, Olsen E, Mitrova E, Alperovitch A, Brandel JP, Mackenzie J, Murray K, Will RG (2006) Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain 129:2278–2287. doi:10.1093/brain/awl159

    PubMed  CAS  Google Scholar 

  • Crozet C, Lezmi S, Flamant F, Samarut J, Baron T, Bencsik A (2007) Peripheral circulation of the prion infectious agent in transgenic mice expressing the ovine prion protein gene in neurons only. J Infect Dis 195:997–1006. doi:10.1086/512085

    PubMed  CAS  Google Scholar 

  • Deleault NR, Harris BT, Rees JR, Supattapone S (2007) Formation of native prions from minimal components in vitro. Proc Natl Acad Sci USA 104:9741–9746. doi:10.1073/pnas.0702662104

    PubMed  CAS  Google Scholar 

  • DeMarco ML, Daggett V (2004) From conversion to aggregation: protofibril formation of the prion protein. Proc Natl Acad Sci USA 101:2293–2298

    PubMed  CAS  Google Scholar 

  • DeMarco ML, Silveira J, Caughey B, Daggett V (2006) Structural properties of prion protein protofibrils and fibrils: an experimental assessment of atomic models. Biochemistry 45:15573–15582. doi:10.1021/bi0612723

    PubMed  CAS  Google Scholar 

  • Dickinson AG, Meikle VM, Fraser H (1968) Identification of a gene which controls the incubation period of some strains of scrapie agent in mice. J Comp Pathol 78:293–299

    PubMed  CAS  Google Scholar 

  • Doh-Ura K, Iwaki T, Caughey B (2000) Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation. J Virol 74:4894–4897

    PubMed  CAS  Google Scholar 

  • Edgeworth JA, Jackson GS, Clarke AR, Weissmann C, Collinge J (2009) Highly sensitive, quantitative cell-based assay for prions adsorbed to solid surfaces. Proc Natl Acad Sci USA 106:3479–3483. doi:10.1073/pnas.0813342106

    PubMed  CAS  Google Scholar 

  • Espinosa PS, Bensalem-Owen MK, Fee DB (2010) Sporadic Creutzfeldt-Jakob disease presenting as nonconvulsive status epilepticus case report and review of the literature. Clin Neurol Neurosurg 112:537–540. doi:10.1016/j.clineuro.2010.03.025

    PubMed  Google Scholar 

  • Everington D, Smith AJ, Ward HJ, Letters S, Will RG, Bagg J (2007) Dental treatment and risk of variant CJD–a case control study. Br Dent J 202:470–471. doi:10.1038/bdj.2007.126

    Google Scholar 

  • Flechsig E, Hegyi I, Enari M, Schwarz P, Collinge J, Weissmann C (2001) Transmission of scrapie by steel-surface-bound prions. Mol Med 7:679–684

    PubMed  CAS  Google Scholar 

  • Fraser H, Dickinson AG (1973) Scrapie in mice. Agent-strain differences in the distribution and intensity of grey matter vacuolation. J Comp Pathol 83:29–40

    PubMed  CAS  Google Scholar 

  • Gajdusek DC, Gibbs CJ, Alpers M (1966) Experimental transmission of a Kuru-like syndrome to chimpanzees. Nature 209:794–796

    PubMed  CAS  Google Scholar 

  • Gambetti P, Puoti G, Zou WQ (2011) Variably protease-sensitive prionopathy: a novel disease of the prion protein. J Mol Neurosci 45:422–424. doi:10.1007/s12031-011-9543-1

    PubMed  CAS  Google Scholar 

  • Gambetti P, Dong Z, Yuan J, Xiao X, Zheng M, Alshekhlee A, Castellani R, Cohen M, Barria MA, Gonzalez-Romero D, Belay ED, Schonberger LB, Marder K, Harris C, Burke JR, Montine T, Wisniewski T, Dickson DW, Soto C, Hulette CM, Mastrianni JA, Kong Q, Zou WQ (2008) A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol 63:697–708. doi:10.1002/ana.21420

    PubMed  CAS  Google Scholar 

  • Geoghegan JC, Miller MB, Kwak AH, Harris BT, Supattapone S (2009) Trans-dominant inhibition of prion propagation in vitro is not mediated by an accessory cofactor. PLoS Pathog 5:e1000535. doi:10.1371/journal.ppat.1000535

    PubMed  Google Scholar 

  • Geschwind MD, Shu H, Haman A, Sejvar JJ, Miller BL (2008a) Rapidly progressive dementia. Ann Neurol 64:97–108. doi:10.1002/ana.21430

    PubMed  Google Scholar 

  • Geschwind MD, Potter CA, Sattavat M, Garcia PA, Rosen HJ, Miller BL, DeArmond SJ (2009) Correlating DWI MRI with pathologic and other features of Jakob-Creutzfeldt disease. Alzheimer Dis Assoc Disord 23:82–87

    PubMed  Google Scholar 

  • Geschwind MD, Tan KM, Lennon VA, Barajas RF Jr, Haman A, Klein CJ, Josephson SA, Pittock SJ (2008b) Voltage-gated potassium channel autoimmunity mimicking Creutzfeldt-Jakob disease. Arch Neurol 65:1341–1346. doi:10.1001/archneur.65.10.1341

    PubMed  Google Scholar 

  • Gibbs CJ Jr, Gajdusek DC, Asher DM, Alpers MP, Beck E, Daniel PM, Matthews WB (1968) Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science 161:388–389

    PubMed  Google Scholar 

  • Glatzel M, Heppner FL, Albers KM, Aguzzi A (2001) Sympathetic innervation of lymphoreticular organs is rate limiting for prion neuroinvasion. Neuron 31:25–34

    PubMed  CAS  Google Scholar 

  • Glatzel M, Abela E, Maissen M, Aguzzi A (2003) Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med 349:1812–1820. doi:10.1056/NEJMoa030351

    PubMed  CAS  Google Scholar 

  • Goldfarb LG, Petersen RB, Tabaton M, Brown P, LeBlanc AC, Montagna P, Cortelli P, Julien J, Vital C, Pendelbury WW (1992) Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 258:806–808

    PubMed  CAS  Google Scholar 

  • Govaerts C, Wille H, Prusiner SB, Cohen FE (2004) Evidence for assembly of prions with left-handed beta-helices into trimers. Proc Natl Acad Sci USA 101:8342–8347. doi:10.1073/pnas.0402254101

    PubMed  CAS  Google Scholar 

  • Green AJ, Thompson EJ, Stewart GE, Zeidler M, McKenzie JM, MacLeod MA, Ironside JW, Will RG, Knight RS (2001) Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 70:744–748

    PubMed  CAS  Google Scholar 

  • Griffith JS (1967) Self-replication and scrapie. Nature 215:1043–1044

    PubMed  CAS  Google Scholar 

  • Hadlow WJ (1959) Scrapie and kuru. Lancet 274:289–290. doi:10.1016/S0140-6736(59)92081-1

    Google Scholar 

  • Hainfellner JA, Brantner-Inthaler S, Cervenakova L, Brown P, Kitamoto T, Tateishi J, Diringer H, Liberski PP, Regele H, Feucht M (1995) The original Gerstmann-Straussler-Scheinker family of Austria: divergent clinicopathological phenotypes but constant PrP genotype. Brain Pathol 5:201–211

    PubMed  CAS  Google Scholar 

  • Head MW, Ritchie D, McLoughlin V, Ironside JW (2003) Investigation of PrPres in dental tissues in variant CJD. Br Dent J 195:339–343. doi:10.1038/sj.bdj.4810536

    PubMed  CAS  Google Scholar 

  • Heath CA, Cooper SA, Murray K, Lowman A, Henry C, MacLeod MA, Stewart GE, Zeidler M, MacKenzie JM, Ironside JW, Summers DM, Knight RS, Will RG (2010) Validation of diagnostic criteria for variant Creutzfeldt-Jakob disease. Ann Neurol 67:761–770. doi:10.1002/ana.21987

    PubMed  Google Scholar 

  • Herzog C, Riviere J, Lescoutra-Etchegaray N, Charbonnier A, Leblanc V, Sales N, Deslys JP, Lasmezas CI (2005) PrPTSE distribution in a primate model of variant, sporadic, and iatrogenic Creutzfeldt-Jakob disease. J Virol 79:14339–14345. doi:10.1128/JVI.79.22.14339-14345.2005

    PubMed  CAS  Google Scholar 

  • Hewitt PE, Llewelyn CA, Mackenzie J, Will RG (2006) Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang 91:221–230. doi:10.1111/j.1423-0410.2006.00833.x

    PubMed  CAS  Google Scholar 

  • Hill AF, Desbruslais M, Joiner S, Sidle KC, Gowland I, Collinge J, Doey LJ, Lantos P (1997) The same prion strain causes vCJD and BSE. Nature 389:448–450, 526. doi:10.1038/38925

    Google Scholar 

  • Hoffman Snyder C, Mishark KJ, Caviness JN, Drazkowski JF, Caselli RJ (2006) Nonvasculitic autoimmune inflammatory meningoencephalitis imitating Creutzfeldt-Jakob disease. Arch Neurol 63:766–768. doi:10.1001/archneur.63.5.766

    PubMed  CAS  Google Scholar 

  • Honda H, Sasaki K, Minaki H, Masui K, Suzuki SO, Doh-Ura K, Iwaki T (2011) Protease-resistant PrP and PrP oligomers in the brain in human prion diseases after intraventricular pentosan polysulfate infusion. Neuropathology. doi:10.1111/j.1440-1789.2011.01245.x

  • Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG (1996) The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 335:924–930. doi:10.1056/NEJM199609263351303

    PubMed  CAS  Google Scholar 

  • Hu WT, Murray JA, Greenaway MC, Parisi JE, Josephs KA (2006) Cognitive impairment and celiac disease. Arch Neurol 63:1440–1446. doi:10.1001/archneur.63.10.1440

    PubMed  Google Scholar 

  • Jacob H, Pyrkosch W, Strube H (1950) The hereditary form of Creutzfeldt-Jakob disease (the Backer family). Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr 184:653–674

    PubMed  CAS  Google Scholar 

  • Jansen C, Voet W, Head MW, Parchi P, Yull H, Verrips A, Wesseling P, Meulstee J, Baas F, van Gool WA, Ironside JW, Rozemuller AJ (2011) A novel seven-octapeptide repeat insertion in the prion protein gene (PRNP) in a Dutch pedigree with Gerstmann-Straussler-Scheinker disease phenotype: comparison with similar cases from the literature. Acta Neuropathol 121:59–68. doi:10.1007/s00401-010-0656-3

    PubMed  CAS  Google Scholar 

  • Karmon Y, Kurzweil A, Lindzen E, Holmlund T, Weinstock-Guttman B (2011) Gerstmann-Straussler-Scheinker syndrome masquerading multiple sclerosis. J Neurol Sci 309:55–57. doi:10.1016/j.jns.2011.07.028

    PubMed  Google Scholar 

  • Kaski D, Mead S, Hyare H, Cooper S, Jampana R, Overell J, Knight R, Collinge J, Rudge P (2009) Variant CJD in an individual heterozygous for PRNP codon 129. Lancet 374:2128. doi:10.1016/S0140-6736(09)61568-3

    PubMed  Google Scholar 

  • Kim EJ, Cho SS, Jeong BH, Kim YS, Seo SW, Na DL, Geschwind MD, Jeong Y (2011) Glucose metabolism in sporadic Creutzfeldt-Jakob disease: a statistical parametric mapping analysis of (18) F-FDG PET. Eur J Neurol. doi:10.1111/j.1468-1331.2011.03570.x

  • Kim JI, Cali I, Surewicz K, Kong Q, Raymond GJ, Atarashi R, Race B, Qing L, Gambetti P, Caughey B, Surewicz WK (2010) Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J Biol Chem 285:14083–14087. doi:10.1074/jbc.C110.113464

    PubMed  CAS  Google Scholar 

  • Kimberlin RH, Walker CA (1978) Evidence that the transmission of one source of scrapie agent to hamsters involves separation of agent strains from a mixture. J Gen Virol 39:487–496

    PubMed  CAS  Google Scholar 

  • Kimberlin RH, Walker CA (1989a) The role of the spleen in the neuroinvasion of scrapie in mice. Virus Res 12:201–211

    PubMed  CAS  Google Scholar 

  • Kimberlin RH, Walker CA (1989b) Pathogenesis of scrapie in mice after intragastric infection. Virus Res 12:213–220

    PubMed  CAS  Google Scholar 

  • Kimberlin RH, Cole S, Walker CA (1987) Temporary and permanent modifications to a single strain of mouse scrapie on transmission to rats and hamsters. J Gen Virol 68:1875–1881

    PubMed  Google Scholar 

  • Korth C, May BC, Cohen FE, Prusiner SB (2001) Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc Natl Acad Sci USA 98:9836–9841. doi:10.1073/pnas.161274798

    PubMed  CAS  Google Scholar 

  • Ladogana A, Sanchez-Juan P, Mitrova E, Green A, Cuadrado-Corrales N, Sanchez-Valle R, Koscova S, Aguzzi A, Sklaviadis T, Kulczycki J, Gawinecka J, Saiz A, Calero M, van Duijn CM, Pocchiari M, Knight R, Zerr I (2009) Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies. J Neurol 256:1620–1628. doi:10.1007/s00415-009-5163-x

    PubMed  CAS  Google Scholar 

  • Lapergue B, Demeret S, Denys V, Laplanche JL, Galanaud D, Verny M, Sazdovitch V, Baulac M, Haik S, Hauw JJ, Bolgert F, Brandel JP, Navarro V (2010) Sporadic Creutzfeldt-Jakob disease mimicking nonconvulsive status epilepticus. Neurology 74:1995–1999. doi:10.1212/WNL.0b013e3181e39703

    PubMed  CAS  Google Scholar 

  • Legname G, Baskakov IV, Nguyen HO, Riesner D, Cohen FE, DeArmond SJ, Prusiner SB (2004) Synthetic mammalian prions. Science 305:673–676. doi:10.1126/science.1100195

    PubMed  CAS  Google Scholar 

  • Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR (2008) Physiology of the prion protein. Physiol Rev 88:673–728. doi:10.1152/physrev.00007.2007

    PubMed  CAS  Google Scholar 

  • Mabbott NA, Bruce ME (2001) The immunobiology of TSE diseases. J Gen Virol 82:2307–2318

    PubMed  CAS  Google Scholar 

  • Mallucci G, Dickinson A, Linehan J, Klohn PC, Brandner S, Collinge J (2003) Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302:871–874. doi:10.1126/science.1090187

    PubMed  CAS  Google Scholar 

  • Masters CL, Gajdusek DC, Gibbs CJ Jr (1981) The familial occurrence of Creutzfeldt-Jakob disease and Alzheimer’s disease. Brain 104:535–558

    PubMed  CAS  Google Scholar 

  • McKinley MP, Bolton DC, Prusiner SB (1983) A protease-resistant protein is a structural component of the scrapie prion. Cell 35:57–62

    PubMed  CAS  Google Scholar 

  • Mead S, Ranopa M, Gopalakrishnan GS, Thompson AG, Rudge P, Wroe S, Kennedy A, Hudson F, MacKay A, Darbyshire JH, Collinge J, Walker AS (2011) PRION-1 scales analysis supports use of functional outcome measures in prion disease. Neurology 77:1674–1683. doi:10.1212/WNL.0b013e3182364890

    PubMed  CAS  Google Scholar 

  • Medori R, Tritschler HJ, LeBlanc A, Villare F, Manetto V, Chen HY, Xue R, Leal S, Montagna P, Cortelli P (1992) Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med 326:444–449. doi:10.1056/NEJM199202133260704

    PubMed  CAS  Google Scholar 

  • Meissner B, Kallenberg K, Sanchez-Juan P, Krasnianski A, Heinemann U, Varges D, Knauth M, Zerr I (2008) Isolated cortical signal increase on MR imaging as a frequent lesion pattern in sporadic Creutzfeldt-Jakob disease. AJNR Am J Neuroradiol 29:1519–1524. doi:10.3174/ajnr.A1122

    PubMed  CAS  Google Scholar 

  • Merz PA, Somerville RA, Wisniewski HM, Iqbal K (1981) Abnormal fibrils from scrapie-infected brain. Acta Neuropathol 54:63–74

    PubMed  CAS  Google Scholar 

  • Merz PA, Kascsak RJ, Rubenstein R, Carp RI, Wisniewski HM (1987) Antisera to scrapie-associated fibril protein and prion protein decorate scrapie-associated fibrils. J Virol 61:42–49

    PubMed  CAS  Google Scholar 

  • Merz PA, Rohwer RG, Kascsak R, Wisniewski HM, Somerville RA, Gibbs CJ Jr, Gajdusek DC (1984) Infection-specific particle from the unconventional slow virus diseases. Science 225:437–440

    PubMed  CAS  Google Scholar 

  • Montrasio F, Frigg R, Glatzel M, Klein MA, Mackay F, Aguzzi A, Weissmann C (2000) Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science 288:1257–1259

    PubMed  CAS  Google Scholar 

  • Morales R, Duran-Aniotz C, Castilla J, Estrada LD, Soto C (2011) De novo induction of amyloid-beta deposition in vivo. Mol Psychiatry. doi:10.1038/mp.2011.120

  • Orru CD, Wilham JM, Raymond LD, Kuhn F, Schroeder B, Raeber AJ, Caughey B (2011) Prion disease blood test using immunoprecipitation and improved quaking-induced conversion. MBio 2:e00078–11. doi:10.1128/mBio.00078-11

    PubMed  Google Scholar 

  • Otto M, Wiltfang J, Tumani H, Zerr I, Lantsch M, Kornhuber J, Weber T, Kretzschmar HA, Poser S (1997a) Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci Lett 225:210–212

    PubMed  CAS  Google Scholar 

  • Otto M, Stein H, Szudra A, Zerr I, Bodemer M, Gefeller O, Poser S, Kretzschmar HA, Mader M, Weber T (1997b) S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurol 244:566–570

    PubMed  CAS  Google Scholar 

  • Owen F, Poulter M, Lofthouse R, Collinge J, Crow TJ, Risby D, Baker HF, Ridley RM, Hsiao K, Prusiner SB (1989) Insertion in prion protein gene in familial Creutzfeldt-Jakob disease. Lancet 1:51–52

    PubMed  CAS  Google Scholar 

  • Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE (1993) Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 90:10962–10966

    PubMed  CAS  Google Scholar 

  • Parchi P, Strammiello R, Giese A, Kretzschmar H (2011) Phenotypic variability of sporadic human prion disease and its molecular basis: past, present, and future. Acta Neuropathol 121:91–112. doi:10.1007/s00401-010-0779-6

    PubMed  CAS  Google Scholar 

  • Parchi P, Strammiello R, Notari S, Giese A, Langeveld JP, Ladogana A, Zerr I, Roncaroli F, Cras P, Ghetti B, Pocchiari M, Kretzschmar H, Capellari S (2009) Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol 118:659–671. doi:10.1007/s00401-009-0585-1

    PubMed  CAS  Google Scholar 

  • Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar H (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224–233

    PubMed  CAS  Google Scholar 

  • Pastrana MA, Sajnani G, Onisko B, Castilla J, Morales R, Soto C, Requena JR (2006) Isolation and characterization of a proteinase K-sensitive PrPSc fraction. Biochemistry 45:15710–15717. doi:10.1021/bi0615442

    PubMed  CAS  Google Scholar 

  • Pattison IH, Jones KM (1968) Modification of a strain of mouse-adapted scrapie by passage through rats. Res Vet Sci 9:408–410

    PubMed  CAS  Google Scholar 

  • Peden A, McCardle L, Head MW, Love S, Ward HJ, Cousens SN, Keeling DM, Millar CM, Hill FG, Ironside JW (2010) Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia 16:296–304. doi:10.1111/j.1365-2516.2009.02181.x

    PubMed  CAS  Google Scholar 

  • Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW (2004) Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364:527–529. doi:10.1016/S0140-6736(04)16811-6

    PubMed  Google Scholar 

  • Peden AH, McGuire LI, Appleford NE, Mallinson G, Wilham JM, Orru CD, Caughey B, Ironside JW, Knight RS, Will RG, Green AJ, Head MW (2011) Sensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking induced conversion. J Gen Virol. doi:10.1099/vir.0.033365-0

  • Peretz D, Scott MR, Groth D, Williamson RA, Burton DR, Cohen FE, Prusiner SB (2001) Strain-specified relative conformational stability of the scrapie prion protein. Protein Sci 10:854–863. doi:10.1110/ps.39201

    PubMed  CAS  Google Scholar 

  • Polymenidou M, Cleveland DW (2011) The seeds of neurodegeneration: prion-like spreading in ALS. Cell 147:498–508. doi:10.1016/j.cell.2011.10.011

    PubMed  CAS  Google Scholar 

  • Polymenidou M, Stoeck K, Glatzel M, Vey M, Bellon A, Aguzzi A (2005) Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease. Lancet Neurol 4:805–814. doi:10.1016/S1474-4422(05)70225-8

    PubMed  CAS  Google Scholar 

  • Prinz M, Heikenwalder M, Junt T, Schwarz P, Glatzel M, Heppner FL, Fu YX, Lipp M, Aguzzi A (2003) Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion. Nature 425:957–962. doi:10.1038/nature02072

    PubMed  CAS  Google Scholar 

  • Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216:136–144

    PubMed  CAS  Google Scholar 

  • Puoti G, Giaccone G, Rossi G, Canciani B, Bugiani O, Tagliavini F (1999) Sporadic Creutzfeldt-Jakob disease: co-occurrence of different types of PrP(Sc) in the same brain. Neurology 53:2173–2176

    PubMed  CAS  Google Scholar 

  • Rainov NG, Tsuboi Y, Krolak-Salmon P, Vighetto A, Doh-Ura K (2007) Experimental treatments for human transmissible spongiform encephalopathies: is there a role for pentosan polysulfate? Expert Opin Biol Ther 7:713–726. doi:10.1517/14712598.7.5.713

    PubMed  CAS  Google Scholar 

  • Roos R, Gajdusek DC, Gibbs CJ Jr (1973) The clinical characteristics of transmissible Creutzfeldt-Jakob disease. Brain 96:1–20

    PubMed  CAS  Google Scholar 

  • Rosenthal NP, Keesey J, Crandall B, Brown WJ (1976) Familial neurological disease associated with spongiform encephalopathy. Arch Neurol 33:252–259

    PubMed  CAS  Google Scholar 

  • Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, Cohen FE, Prusiner SB (1998) Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 4:1157–1165. doi:10.1038/2654

    PubMed  CAS  Google Scholar 

  • Sailer A, Bueler H, Fischer M, Aguzzi A, Weissmann C (1994) No propagation of prions in mice devoid of PrP. Cell 77:967–968

    PubMed  CAS  Google Scholar 

  • Santoro D, Colombo I, Ghione I, Peverelli L, Bresolin N, Sciacco M, Prelle A (2011) Steroid-responsive Hashimoto encephalopathy mimicking Creutzfeldt-Jakob disease. Neurol Sci 32:719–722. doi:10.1007/s10072-011-0610-8

    PubMed  Google Scholar 

  • Secker TJ, Herve R, Keevil CW (2011) Adsorption of prion and tissue proteins to surgical stainless steel surfaces and the efficacy of decontamination following dry and wet storage conditions. J Hosp Infect 78:251–255. doi:10.1016/j.jhin.2011.03.021

    PubMed  CAS  Google Scholar 

  • Shyng SL, Lehmann S, Moulder KL, Harris DA (1995) Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells. J Biol Chem 270:30221–30229

    PubMed  CAS  Google Scholar 

  • Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, Caughey B (2005) The most infectious prion protein particles. Nature 437:257–261. doi:10.1038/nature03989

    PubMed  CAS  Google Scholar 

  • Sim VL, Caughey B (2009a) Ultrastructures and strain comparison of under-glycosylated scrapie prion fibrils. Neurobiol Aging 30:2031–2042. doi:10.1016/j.neurobiolaging.2008.02.016

    PubMed  CAS  Google Scholar 

  • Sim VL, Caughey B (2009b) Recent advances in prion chemotherapeutics. Infect Disord Drug Targets 9:81–91

    PubMed  CAS  Google Scholar 

  • Sim VL (2012) Prion Disease: Chemotherapeutic Strategies. Infect Disord Drug Targets 12:144–160

    PubMed  CAS  Google Scholar 

  • Soldevila M, Calafell F, Andres AM, Yague J, Helgason A, Stefansson K, Bertranpetit J (2003) Prion susceptibility and protective alleles exhibit marked geographic differences. Hum Mutat 22:104–105. doi:10.1002/humu.9157

    PubMed  Google Scholar 

  • Steinhoff BJ, Zerr I, Glatting M, Schulz-Schaeffer W, Poser S, Kretzschmar HA (2004) Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease. Ann Neurol 56:702–708. doi:10.1002/ana.20261

    PubMed  Google Scholar 

  • Steinhoff BJ, Racker S, Herrendorf G, Poser S, Grosche S, Zerr I, Kretzschmar H, Weber T (1996) Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol 53:162–166

    PubMed  CAS  Google Scholar 

  • Tateishi J, Brown P, Kitamoto T, Hoque ZM, Roos R, Wollman R, Cervenakova L, Gajdusek DC (1995) First experimental transmission of fatal familial insomnia. Nature 376:434–435. doi:10.1038/376434a0

    PubMed  CAS  Google Scholar 

  • Taylor DM (1996) Bovine spongiform encephalopathy–the beginning of the end? Br Vet J 152:501–518

    PubMed  CAS  Google Scholar 

  • Telling GC, Parchi P, DeArmond SJ, Cortelli P, Montagna P, Gabizon R, Mastrianni J, Lugaresi E, Gambetti P, Prusiner SB (1996) Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274:2079–2082

    PubMed  CAS  Google Scholar 

  • Thomzig A, Spassov S, Friedrich M, Naumann D, Beekes M (2004) Discriminating scrapie and bovine spongiform encephalopathy isolates by infrared spectroscopy of pathological prion protein. J Biol Chem 279:33847–33854. doi:10.1074/jbc.M403730200

    PubMed  CAS  Google Scholar 

  • Todd NV, Morrow J, Doh-ura K, Dealler S, O’Hare S, Farling P, Duddy M, Rainov NG (2005) Cerebroventricular infusion of pentosan polysulphate in human variant Creutzfeldt-Jakob disease. J Infect 50:394–396. doi:10.1016/j.jinf.2004.07.015

    PubMed  CAS  Google Scholar 

  • Tsuboi Y, Doh-Ura K, Yamada T (2009) Continuous intraventricular infusion of pentosan polysulfate: clinical trial against prion diseases. Neuropathology 29:632–636. doi:10.1111/j.1440-1789.2009.01058.x

    PubMed  Google Scholar 

  • Tzaban S, Friedlander G, Schonberger O, Horonchik L, Yedidia Y, Shaked G, Gabizon R, Taraboulos A (2002) Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. Biochemistry 41:12868–12875

    PubMed  CAS  Google Scholar 

  • Urayama A, Morales R, Niehoff ML, Banks WA, Soto C (2011) Initial fate of prions upon peripheral infection: half-life, distribution, clearance, and tissue uptake. FASEB J 25:2792–2803. doi:10.1096/fj.11-180729

    PubMed  CAS  Google Scholar 

  • Valcour V, Haman A, Cornes S, Lawall C, Parsa AT, Glaser C, Yagi S, Tihan T, Bhatnagar J, Geschwind M, Vanderbilt Continuing Medical Education online (2008) A case of enteroviral meningoencephalitis presenting as rapidly progressive dementia. Nat Clin Pract Neurol 4:399–403. doi:10.1038/ncpneuro0804

    PubMed  Google Scholar 

  • Van Everbroeck B, Boons J, Cras P (2005) Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease. Clin Neurol Neurosurg 107:355–360. doi:10.1016/j.clineuro.2004.12.002

    PubMed  Google Scholar 

  • Van Everbroeck B, Green AJ, Pals P, Martin JJ, Cras P (1999) Decreased levels of amyloid-beta 1-42 in cerebrospinal fluid of Creutzfeldt-Jakob disease patients. J Alzheimers Dis 1:419–424

    PubMed  Google Scholar 

  • Vitali P, Maccagnano E, Caverzasi E, Henry RG, Haman A, Torres-Chae C, Johnson DY, Miller BL, Geschwind MD (2011) Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology 76:1711–1719. doi:10.1212/WNL.0b013e31821a4439

    PubMed  CAS  Google Scholar 

  • Wadsworth JD, Joiner S, Hill AF, Campbell TA, Desbruslais M, Luthert PJ, Collinge J (2001) Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 358:171–180

    PubMed  CAS  Google Scholar 

  • Wang F, Wang X, Yuan CG, Ma J (2010) Generating a prion with bacterially expressed recombinant prion protein. Science 327:1132–1135. doi:10.1126/science.1183748

    PubMed  CAS  Google Scholar 

  • Ward HJ (2006) Evidence of a new human genotype susceptible to variant CJD. Euro Surveill 11:E060601.3

    PubMed  CAS  Google Scholar 

  • Wilham JM, Orru CD, Bessen RA, Atarashi R, Sano K, Race B, Meade-White KD, Taubner LM, Timmes A, Caughey B (2010) Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathog 6:e1001217. doi:10.1371/journal.ppat.1001217

    PubMed  Google Scholar 

  • Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347:921–925

    PubMed  CAS  Google Scholar 

  • Wille H, Michelitsch MD, Guenebaut V, Supattapone S, Serban A, Cohen FE, Agard DA, Prusiner SB (2002) Structural studies of the scrapie prion protein by electron crystallography. Proc Natl Acad Sci USA 99:3563–3568. doi:10.1073/pnas.052703499

    PubMed  CAS  Google Scholar 

  • Wille H, Bian W, McDonald M, Kendall A, Colby DW, Bloch L, Ollesch J, Borovinskiy AL, Cohen FE, Prusiner SB, Stubbs G (2009) Natural and synthetic prion structure from X-ray fiber diffraction. Proc Natl Acad Sci USA 106:16990–16995. doi:10.1073/pnas.0909006106

    PubMed  CAS  Google Scholar 

  • Wiltfang J, Otto M, Baxter HC, Bodemer M, Steinacker P, Bahn E, Zerr I, Kornhuber J, Kretzschmar HA, Poser S, Ruther E, Aitken A (1999) Isoform pattern of 14-3-3 proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurochem 73:2485–2490

    PubMed  CAS  Google Scholar 

  • Xiao X, Miravalle L, Yuan J, McGeehan J, Dong Z, Wyza R, MacLennan GT, Golichowski AM, Kneale G, King N, Kong Q, Spina S, Vidal R, Ghetti B, Roos K, Gambetti P, Zou WQ (2009) Failure to detect the presence of prions in the uterine and gestational tissues from a Gravida with Creutzfeldt-Jakob disease. Am J Pathol 174:1602–1608. doi:10.2353/ajpath.2009.081045

    PubMed  CAS  Google Scholar 

  • Young GS, Geschwind MD, Fischbein NJ, Martindale JL, Henry RG, Liu S, Lu Y, Wong S, Liu H, Miller BL, Dillon WP (2005) Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol 26:1551–1562

    PubMed  Google Scholar 

  • Yull HM, Ritchie DL, Langeveld JP, van Zijderveld FG, Bruce ME, Ironside JW, Head MW (2006) Detection of type 1 prion protein in variant Creutzfeldt-Jakob disease. Am J Pathol 168:151–157. doi:10.2353/ajpath.2006.050766

    PubMed  CAS  Google Scholar 

  • Zerr I, Bodemer M, Racker S, Grosche S, Poser S, Kretzschmar HA, Weber T (1995) Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease. Lancet 345:1609–1610

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Valerie L. Sim .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Basel

About this chapter

Cite this chapter

Sim, V.L. (2013). Prion Diseases. In: Jackson, A. (eds) Viral Infections of the Human Nervous System. Birkhäuser Advances in Infectious Diseases. Springer, Basel. https://doi.org/10.1007/978-3-0348-0425-7_15

Download citation

Publish with us

Policies and ethics